Molecular Targeting Technologies, Inc.   Report issue

For profit Phase 2
Founded: West Chester PA United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2008
NCT00614354
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now